Natori, Y.; Suga, J.; Tokuda, E.; Tachibana, K.; Imai, J.-i.; Honma, R.; Azami, Y.; Noda, M.; Sasaki, E.; Watanabe, S.;
et al. E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor α Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer. Cancers 2023, 15, 539.
https://doi.org/10.3390/cancers15020539
AMA Style
Natori Y, Suga J, Tokuda E, Tachibana K, Imai J-i, Honma R, Azami Y, Noda M, Sasaki E, Watanabe S,
et al. E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor α Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer. Cancers. 2023; 15(2):539.
https://doi.org/10.3390/cancers15020539
Chicago/Turabian Style
Natori, Yutaka, Junko Suga, Emi Tokuda, Kazunoshin Tachibana, Jun-ichi Imai, Reiko Honma, Yusuke Azami, Masaru Noda, Eisaku Sasaki, Shinya Watanabe,
and et al. 2023. "E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor α Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer" Cancers 15, no. 2: 539.
https://doi.org/10.3390/cancers15020539
APA Style
Natori, Y., Suga, J., Tokuda, E., Tachibana, K., Imai, J. -i., Honma, R., Azami, Y., Noda, M., Sasaki, E., Watanabe, S., Ohtake, T., & Saji, S.
(2023). E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor α Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer. Cancers, 15(2), 539.
https://doi.org/10.3390/cancers15020539